Free tool
Healthcare stocks
We cover 92 companies in the Healthcare sector. The median market value in the group is $410.82M. Across the group, the median move over the past trading day is +0.08%. 93% of the 86 with a 200-day average trade above it. Price change over the past year runs from −21.3% to +327.8% across the middle 80 percent of the group, with a median of +46.6%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
92 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| MRCK34.SA | Merck & Co., Inc. | 101.37 BRL | +20.05% | +39.73% | +81.07% |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| AMGN34.SA | Amgen Inc. | 81.32 BRL | +13.94% | +69.69% | +47.79% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | 67.15 BRL | +9.49% | −0.22% | +22.22% |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% |
| BLFS | BioLife Solutions, Inc. | $37.00 | +15.70% | +54.88% | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $125.34 | +57.30% | +67.03% | +357.45% |
| ETON | Eton Pharmaceuticals, Inc. | $62.62 | +34.20% | +285.12% | +262.38% |
| FBRX | Forte Biosciences, Inc. | $76.99 | +0.44% | +226.09% | +589.87% |
| SPTX | Seaport Therapeutics, Inc. | $27.84 | +39.90% | +40.32% | +40.32% |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% |
| KALV | KalVista Pharmaceuticals Inc | $27.00 | 0.00% | +74.64% | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $36.53 | +33.22% | +120.19% | +786.65% |
| OMER | Omeros Corporation | $18.22 | +61.52% | +11.23% | +328.71% |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% |
| CRON.TO | Cronos Group Inc. | 4.95 CAD | +23.75% | +34.15% | +39.83% |
| CRON | Cronos Group Inc. | $3.55 | +24.56% | +31.48% | +38.67% |
| 6523.T | PHC Holdings Corporation | 1,527.00 JPY | +36.71% | +37.93% | +58.42% |
| JANX | Janux Therapeutics, Inc. | $18.89 | +25.93% | +38.39% | −19.10% |
| IMMX | Immix Biopharma, Inc. | $14.07 | +66.71% | +159.12% | +617.86% |
| HELP | Cybin D/B/A Helus Pharma | $13.63 | +79.34% | +64.61% | +77.71% |
| ACHV | Achieve Life Sciences, Inc. | $8.27 | +33.82% | +66.40% | +177.52% |
| VREX | Varex Imaging Corporation | $18.48 | +66.04% | +58.63% | +61.40% |
| 4588.T | Oncolys BioPharma Inc. | 4,080.00 JPY | +66.46% | +173.09% | +539.50% |
| SOPH | SOPHiA GENETICS SA | $8.53 | +53.14% | +82.66% | +156.16% |
| ASMB | Assembly Biosciences, Inc. | $35.42 | +38.52% | +4.95% | +36.81% |
| OABI | OmniAb, Inc. | $4.81 | +144.16% | +155.85% | +198.76% |
| BHVN34.SA | BIOHAVEN LTDDRN | 23.68 BRL | 0.00% | −1.09% | −18.03% |
| AQST | Aquestive Therapeutics, Inc. | $5.39 | +43.35% | −16.43% | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% |
| ICLR34.SA | ICON PLC DRN | 41.72 BRL | −2.07% | −17.97% | −14.33% |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% |
| MEDI.OL | Medistim ASA | 263.00 NOK | +16.37% | +4.43% | +4.43% |
| REG1V.HE | Revenio Group Oyj | 14.78 EUR | +16.56% | −33.12% | −38.54% |
| SENS | Senseonics Holdings, Inc. | $9.34 | +90.22% | +58.57% | +0.43% |
| SGHT | Sight Sciences, Inc. | $8.37 | +57.92% | +11.90% | +97.87% |
| KSI.TO | kneat.com, inc. | 6.50 CAD | +0.46% | +30.52% | +19.93% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $15.83 | +175.30% | +153.28% | −8.44% |
| MCTA | Charming Medical Limited | $29.36 | 0.00% | 0.00% | +319.36% |
| CARL | Carlsmed, Inc. | $16.18 | +31.44% | +39.12% | +16.40% |
| CCRN | Cross Country Healthcare Inc | $13.25 | 0.00% | +64.39% | +0.38% |
| TBRG | TruBridge Inc | $26.24 | 0.00% | +25.55% | +30.42% |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% |
| E2NO34.SA | Enovis Corporation | 34.59 BRL | +7.86% | +12.74% | −19.24% |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | 1.92 BRL | +214.75% | −29.41% | −33.79% |
| CGS.AX | Cogstate Limited | 3.20 AUD | +22.88% | +39.52% | +85.76% |
| 219A.T | HEARTSEED INC | 2,435.00 JPY | +48.48% | +34.90% | −30.13% |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% |
| RCEL | AVITA Medical, Inc. | $10.59 | +129.72% | +205.19% | +133.77% |
| AVH.AX | AVITA Medical, Inc. | 2.87 AUD | +117.05% | +160.45% | +106.12% |
| SMTI | Sanara MedTech Inc. | $34.65 | +30.07% | +50.00% | +2.09% |
| ANCR.L | Animalcare Group PLC | 335.00 GBP | 0.00% | +40.76% | +28.86% |
| YDES | YD Bio Ltd | $4.34 | +88.70% | −63.83% | −63.83% |
| MED.DE | MEDICLIN Aktiengesellschaft | 5.45 EUR | +31.64% | +51.39% | +75.81% |
| BDSX | Biodesix, Inc. | $30.60 | +45.51% | +373.68% | +225.53% |
| SUS.ST | Surgical Science Sweden AB (publ) | 50.85 SEK | +49.82% | +63.82% | −48.69% |
| 6078.T | Value HR Co.,Ltd. | 1,631.00 JPY | +4.48% | +6.53% | +6.39% |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% |
| 4820.T | EM Systems Co., Ltd. | 602.00 JPY | +6.17% | −22.62% | −18.79% |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% |
| ACB | Aurora Cannabis Inc. | $4.00 | +47.06% | −7.83% | −24.95% |
| ACB.TO | Aurora Cannabis Inc. | 5.54 CAD | +44.65% | −6.73% | −24.93% |
| CRDL | Cardiol Therapeutics Inc. | $2.14 | +78.33% | +115.29% | +91.07% |
| CRDL.TO | Cardiol Therapeutics Inc. | 2.97 CAD | +74.71% | +118.38% | +90.38% |
| 4577.T | Daito Pharmaceutical Co.,Ltd. | 1,380.00 JPY | +6.73% | +3.16% | +14.45% |
| XLY.TO | Auxly Cannabis Group Inc. | 3.13 CAD | +19.92% | +2058.62% | +1919.35% |
| NGEN | NervGen Pharma Corp. | $2.21 | +37.27% | −62.41% | −8.30% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.30 | +24.38% | +43.58% | +7.93% |
| ORMP | Oramed Pharmaceuticals Inc. | $5.34 | +28.06% | +96.84% | +159.19% |
| AOTI.L | AOTI, Inc. | 142.50 GBP | +35.71% | +418.18% | +159.09% |
| XGN | Exagen Inc. | $7.67 | +72.36% | +26.99% | −19.69% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | 2,892.00 JPY | +4.82% | +10.10% | +21.78% |
| SPRB | Spruce Biosciences, Inc. | $61.48 | +47.79% | −32.22% | +721.93% |
| ASRT | Assertio Holdings Inc | $23.50 | 0.00% | +157.11% | +103.46% |
| MRC.WA | Mercator Medical S.A. | 60.40 PLN | +18.43% | +52.53% | +35.88% |
| BICO.ST | BICO Group AB (publ) | 19.92 SEK | +36.25% | −1.19% | −17.00% |
| EMPG | Empro Group Inc | $17.36 | 0.00% | 0.00% | +76.60% |
| PAX.ST | Paxman AB (publ) | 57.50 SEK | +26.37% | +2.68% | −21.45% |
| XI3.F | Bioceltix S.A. | 20.40 EUR | +7.59% | −16.22% | −28.67% |
| CPIX | Cumberland Pharmaceuticals Inc. | $8.97 | +69.86% | +125.38% | +163.82% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| BMEA | Biomea Fusion, Inc. | $1.71 | +36.80% | +27.61% | −8.06% |
| A2ZT34.SA | Azenta, Inc. | 14.16 BRL | +16.64% | +50.80% | +50.80% |
| SDI.AX | SDI Ltd | 1.40 AUD | 0.00% | +51.08% | +60.41% |
| ALECR.PA | Eurofins-Cerep SA | 17,700.00 EUR | +8.59% | −0.56% | −3.80% |
| LUNG | Pulmonx Corporation | $2.50 | +100.00% | +8.70% | +34.41% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.